Orale behandeling bij kankergerelateerde VTE net zo effectief

Delen via:
ASH Annual Meeting 2017

Log hier in om volledige toegang te krijgen.

Login of Account maken

 

Bronnen:
Raskob GE, Van Es N, Verhamme P, et al. A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study. ASH 59th Annual Meeting & Exhibition, abstract LBA-6.